Navigation Links
Facet Solution's AFRS(TM) Implant Demonstrates Positive Clinical Results After One Year Follow Up
Date:10/15/2007

LOGAN, Utah, Oct. 15 /PRNewswire/ -- Facet Solutions, Inc. announced today that it has completed one year follow-up on the first cohort of patients to receive its Anatomic Facet Replacement System (AFRS(TM)). The clinical outcomes for these patients at one year include a significant decline in leg and back pain; improved motion and function; and no post-operative complications. Additionally, the first patient in the AFRS(TM) study has completed the two year follow up evaluation with similarly positive results.

The AFRS(TM) has been developed by Facet Solutions, Inc. to provide patients with lumbar spinal stenosis and facet degeneration a motion preserving alternative to lumbar spinal fusion. The AFRS(TM) procedure includes replacing the diseased facet joint with an anatomic implant that restores the natural motion, stability, and balance to the lumbar spine.

An international team of Orthopedic surgeons began the initial AFRS(TM) study at the Hospital Servidor Publico Estadol in Sao Paulo in late September 2005. The team included Dr. Allen Carl of Albany Medical Center in Albany, New York and Dr. Carlos Oliveira of Sao Paulo, Brazil.

"I believe that the early clinical results for the AFRS(TM) clearly demonstrate that this new treatment option is improving the quality of life for my patients who would otherwise lose significant motion using current fusion or dynamic stabilization devices," Dr. Oliviera stated. "In fact, many of my patients were having fusions and would come back four and five years later needing a subsequent fusion at adjacent levels as a result of the reduction in motion at the original fused level of the spine. I anticipate that this technology will ultimately become the surgical standard of care for spinal stenosis patients in the future."

"Facet Solutions is very pleased with the early clinical experience," added Eric Bannon, VP of Clinical Affairs. "The company looks forward to expanding this clinical outcome data with results from an ongoing FDA approved IDE Study which was recently expanded to eight sites within the United States."

The summary findings from this evaluation will be presented a the Science of Facet Joint Repair and Total Posterior Arthroplasty Symposium which will be held in Austin, Texas at the Omni Hotel on Monday, October 22, 2007 at 6:30 PM.

* Note: AFRS(TM) is an investigational device in the United States. It is

limited by United States (U.S.) Federal Law for investigational use

only.

About Facet Solutions

Facet Solutions, Inc. is a privately held, venture backed company that is focused on developing and commercializing surgical devices for the treatment of facet related spinal disorders. Facet Solutions has received venture capital from its partners De Novo Ventures, Pequot Ventures, and Spray Venture Partners. Facet Solutions is FDA registered and is certified to ISO 13485.


'/>"/>
SOURCE Facet Solutions, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. The many facets of milk and its health potential
2. The Multi-Faceted Chemical Benzene
3. Multifaceted Stress: Mere thought is stressful!
4. Solutions Being Sought For Prevention Of Rickets
5. Mental Hospitals Offer More Problems than Solutions
6. Sex Workers Adopt IT Solutions to Fight AIDS
7. Bilcare Signs Pact With Honeywell for Packaging Solutions
8. Planning for Good Health Resolutions
9. Simple Solutions to Postpartum Weight Retention
10. Solutions Possible for Providing Water and Sanitation in Poor Urban Settlements, Says WaterAid
11. Silicon eye implants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from PsychTests.com reveals that behind the tendency to set low expectations ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: